search
Back to results

Methods of Computed Tomography Screening and Management of Lung Cancer

Primary Purpose

Lung Neoplasms, Computed Tomography, Mass Screening

Status
Unknown status
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
lung cancer screening
Sponsored by
Tianjin Medical University Cancer Institute and Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional screening trial for Lung Neoplasms

Eligibility Criteria

40 Years - 74 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Aged 40-74 years;
  • Resident in the Hexi district of Tianjin city for at least 3 years;
  • Having no self-reported history of any malignant tumor.

Exclusion Criteria:

  • Pregnant woman will be excluded.

Sites / Locations

  • Tianjin Medical University Cancer Institute And HospitalRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

lung cancer screening

Arm Description

Participants will undergo a chest CT scan in the Department of Radiology at Tianjin Cancer Hospital. All scans will be performed using the same CT system: Definition AS. Two readings of the images will be performed. In the first image reading, the CT images will be read by specially trained Chinese resident radiologist and checked by one of two senior Chinese radiologists. Lung Cancer Screening (version 2. 2018) Guidelines of the National Comprehensive Cancer Network (NCCN) will be used for the management of lung nodules. This guideline recommends management of lung nodules based on diameter. In the second reading, a semi-automated volumetry software will be used to measure the volume and evaluate the other parameters of lung nodules. At baseline and one year after baseline, data about general characteristics, risk factors of lung cancer, and health status of the participants will be collected.

Outcomes

Primary Outcome Measures

number of clinically diagnosed lung cancer
The number of clinically diagnosed lung cancer will be collected through the hospital information system and by contacting the participants or their relatives using a questionnaire.
number of lung cancer death
The number of lung cancer death will be collected through the hospital information system and by contacting the relatives of the participants using a questionnaire.

Secondary Outcome Measures

Full Information

First Posted
June 18, 2019
Last Updated
June 19, 2019
Sponsor
Tianjin Medical University Cancer Institute and Hospital
Collaborators
University Medical Center Groningen, Shanghai Changzheng Hospital, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
search

1. Study Identification

Unique Protocol Identification Number
NCT03992833
Brief Title
Methods of Computed Tomography Screening and Management of Lung Cancer
Official Title
Methods of Computed Tomography Screening and Management of Lung Cancer in Tianjin: A Population-based Cohort Study
Study Type
Interventional

2. Study Status

Record Verification Date
June 2019
Overall Recruitment Status
Unknown status
Study Start Date
May 1, 2017 (Actual)
Primary Completion Date
May 2020 (Anticipated)
Study Completion Date
September 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Tianjin Medical University Cancer Institute and Hospital
Collaborators
University Medical Center Groningen, Shanghai Changzheng Hospital, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
European lung cancer screening studies using computed tomography (CT) have shown that a management protocol based on measuring lung nodule volume and volume doubling time (VDT) is more specific for early lung cancer detection than a diameter-based protocol. However, whether this also applies to a Chinese population is unclear. The aim of this study is to compare the diagnostic performance of a volume-based protocol with a diameter-based protocol for lung cancer detection and optimize the nodule management criteria for a Chinese population.
Detailed Description
In this population-based study, participants will undergo a low-dose chest CT scan for two rounds. At baseline, the first CT scan will be performed in all participants and their data will be collected. One-year after the baseline, a second CT scan will be performed and data will be collected again. CT images of each participant will be read twice independently by two groups of readers after the baseline and 1-year follow-up scans. In the first reading, the detected lung nodules are evaluated for diameter and managed according to a routine diameter-based protocol. The clinical management of participants are based on the first reading. In the second reading, each scan will be interpreted again by radiologists, blinded to the first reading. Semi-automated volumetry software will be used. The lung nodules will be evaluated for volume and management will be simulated according to a European volume-based protocol. Participants will be followed up and any diagnosis of lung cancer and related information will be collected at the fourth year through the hospital information system and by contacting the participants or their relatives.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lung Neoplasms, Computed Tomography, Mass Screening, Lung Nodules

7. Study Design

Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
4000 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
lung cancer screening
Arm Type
Experimental
Arm Description
Participants will undergo a chest CT scan in the Department of Radiology at Tianjin Cancer Hospital. All scans will be performed using the same CT system: Definition AS. Two readings of the images will be performed. In the first image reading, the CT images will be read by specially trained Chinese resident radiologist and checked by one of two senior Chinese radiologists. Lung Cancer Screening (version 2. 2018) Guidelines of the National Comprehensive Cancer Network (NCCN) will be used for the management of lung nodules. This guideline recommends management of lung nodules based on diameter. In the second reading, a semi-automated volumetry software will be used to measure the volume and evaluate the other parameters of lung nodules. At baseline and one year after baseline, data about general characteristics, risk factors of lung cancer, and health status of the participants will be collected.
Intervention Type
Other
Intervention Name(s)
lung cancer screening
Intervention Description
In the first reading, according to the NCCN lung cancer screening guideline, participants with a solid nodule≤ 5 mm in diameter will be referred to undergo follow-up CT 1 year after the baseline. Participants with a solid nodule 6-14 mm will be referred to undergo follow-up thorax CT 3-6 months after the baseline. Participants with a solid nodule ≥ 15 mm will be referred to a multidisciplinary team for clinical investigation. The simulated management will be based on the volume of lung nodule and volume doubling time from the second reading, lung nodules will be reclassified according to the reference values from the European volume-based lung nodule management protocol. According to the European volume-based protocol, the solid and part-solid lung nodules will be reclassified into three groups: nodules with a volume < 100 mm3 (negative), nodules with a volume of 100-300 mm3 (indeterminate), and nodules with a volume > 300 mm3 (positive).
Primary Outcome Measure Information:
Title
number of clinically diagnosed lung cancer
Description
The number of clinically diagnosed lung cancer will be collected through the hospital information system and by contacting the participants or their relatives using a questionnaire.
Time Frame
at the fourth year from baseline
Title
number of lung cancer death
Description
The number of lung cancer death will be collected through the hospital information system and by contacting the relatives of the participants using a questionnaire.
Time Frame
at the fourth year from baseline

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
74 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Aged 40-74 years; Resident in the Hexi district of Tianjin city for at least 3 years; Having no self-reported history of any malignant tumor. Exclusion Criteria: Pregnant woman will be excluded.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Zhaoxiang Ye, Professor
Phone
+8622-23340123
Email
yezhaoxiang@163.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Zhaoxiang Ye, Professor
Organizational Affiliation
Tianjin Medical University Cancer Institute and Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Tianjin Medical University Cancer Institute And Hospital
City
Tianjin
State/Province
Tianjin
ZIP/Postal Code
300060
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Zhaoxiang Ye, M.D. & Ph.D.
Phone
8622-23340123
Email
yezhaoxiang@163.com

12. IPD Sharing Statement

Learn more about this trial

Methods of Computed Tomography Screening and Management of Lung Cancer

We'll reach out to this number within 24 hrs